Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How have the makers of pseudoephedrine cold and cough remedies dealt with the problem of their products being turned into meth?

0
Posted

How have the makers of pseudoephedrine cold and cough remedies dealt with the problem of their products being turned into meth?

0

Ever since the federal government first tried getting DEA regulations in the mid-80s to deal with the meth problem, pharmaceutical companies have known that these products could be misused and turned into meth. By the 1990s, with the DEA keeping up pressure to constrict the supply of ephedrine and pseudoepedrine going to meth, Pfizer, maker of the popular Sudafed, tried including additives that would make it harder for meth cooks to extract pseudoephedrine. However, the additives made it harder for the body to absorb the decongestant and the work was abandoned. And Warner-Lambert Co., now owned by Pfizer, holds the patent to another possible solution: a “mirror image” form of pseudoephedrine that can’t be turned into methamphetamine. But product development hasn’t been pursued because getting FDA approval would be a long, very expensive road. (See interview with Pfizer’s Steven Robins). Over the years, Congress has not seriously debated financing research into a cold remedy that can’t

0

Ever since the federal government first tried getting DEA regulations in the mid-80s to deal with the meth problem, pharmaceutical companies have known that these products could be misused and turned into meth. By the 1990s, with the DEA keeping up pressure to constrict the supply of ephedrine and pseudoepedrine going to meth, Pfizer, maker of the popular Sudafed, tried including additives that would make it harder for meth cooks to extract pseudoephedrine. However, the additives made it harder for the body to absorb the decongestant and the work was abandoned. And Warner-Lambert Co., now owned by Pfizer, holds the patent to another possible solution: a “mirror image” form of pseudoephedrine that can’t be turned into methamphetamine. But product development hasn’t been pursued because getting FDA approval would be a long, very expensive road. (See interview with Pfizer’s Steven Robins). Over the years, Congress has not seriously debated financing research into a cold remedy that can’t

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123